Is the price fair?
What HQY's price assumes
HealthEquity, Inc. trades at 39.1× earnings against 39.1× for the median Health Information Services name, cheaper than its own group.
39.1
Trailing P/E · Health Information Services median 39.1 · cheaper than the typical name in its group
- Price / sales
- 5.21
Price / sales · as of 2026-Q2
- Free cash flow yield
- 6.8%
Free cash flow yield · Health Information Services median 5.9%
- Growth the price implies
- +1.5%
Growth the price implies · The price pays for +1.5% free cash flow growth a year for a decade; the business has delivered +41% a year over the last three.
Details›
- Price / book2026-Q2
- 3.41
- EV / EBIT2026-Q2
- 22.4
- EV / sales2026-Q2
- 5.72
- Healthcare median P/E362 names
- 31.5
- Health Information Services median P/E14 names
- 39.1
- Free cash flow, trailing twelve months
- $488M
- Market capitalisation
- $7.14B
- 3-year revenue growth
- +14%
- 3-year free cash flow growth
- +41%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $177.00 |
| Its own P/E history, median | $192.74 |
| Its own P/E history, upper quartile | $217.09 |
| 52-week range | $73.21 – $106.83 |
| Today | $104.38 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #10 of 14 by Smart Score